Study says patients in private rooms less likely to get fatal HAI

Hospitals with mostly private rooms had 33 percent fewer central line infections


Patients who stay in private rooms have a reduced risk of central line infections, according to an article on the Becker's Clinical Leadership and Infection Control website.

The study, conducted by researchers at the University of North Texas Health Science Center, looked at the records of more than 1 million patients in 335 Texas hospitals.

The study found that hospitals with mostly private rooms had 33 percent fewer central line infections than hospitals with mostly double occupancy rooms.

The mortality risk due to central line infections was more than twice as high in hospitals with mostly double occupancy rooms.

Read the article.

 

 



August 31, 2018


Topic Area: Infection Control


Recent Posts

Hospitals Are Energy Super-Users. Why Is It So Hard to Modernize Them?

Managers face the ongoing challenge of finding a practical way to fund improvements while competing with capital priorities.


Encompass Health Rehabilitation Hospital of Bangor Officially Opens

Encompass Health Bangor is the company’s first wholly owned hospital in Maine.


Early Entry: Manager's Critical Role in Construction Planning

Facilities managers should seek a seat at the table early to shape decisions that affect operations and continuity of care from the onset.


The Evolution of Lighting in Patient Care

Lighting is a significant investment that healthcare facility managers can make to aid in healing.


HealthPartners and Essentia Health to Combine Organizations

The organizations anticipate the combination will be effective Jan. 1, 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.